Geode Capital Management
HUMA icon

Geode Capital Management’s Humacyte HUMA Stock Holding History

Geode Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Sell
2,185,225
-1,472,883
-40% -$1.36M ﹤0.01% 3229
2026
Q1 		$2.22M Sell
3,658,108
-62,328
-2% -$64.8K ﹤0.01% 3081
2025
Q4 		$3.57M Buy
3,720,436
+624,220
+20% +$884K ﹤0.01% 2935
2025
Q3 		$5.39M Buy
3,096,216
+147,708
+5% +$289K ﹤0.01% 2740
2025
Q2 		$6.16M Buy
2,948,508
+738,142
+33% +$1.42M ﹤0.01% 2628
2025
Q1 		$3.77M Buy
2,210,366
+75,233
+4% +$282K ﹤0.01% 2791
2024
Q4 		$10.8M Buy
2,135,133
+94,915
+5% +$470K ﹤0.01% 2331
2024
Q3 		$11.1M Buy
2,040,218
+179,120
+10% +$1.18M ﹤0.01% 2319
2024
Q2 		$8.93M Buy
1,861,098
+510,560
+38% +$2.66M ﹤0.01% 2394
2024
Q1 		$4.2M Buy
1,350,538
+24,863
+2% +$83.6K ﹤0.01% 2788
2023
Q4 		$3.77M Buy
1,325,675
+96,596
+8% +$248K ﹤0.01% 2845
2023
Q3 		$3.6M Buy
1,229,079
+127,112
+12% +$421K ﹤0.01% 2800
2023
Q2 		$3.15M Buy
1,101,967
+48,034
+5% +$173K ﹤0.01% 2943
2023
Q1 		$3.26M Buy
1,053,933
+178,742
+20% +$508K ﹤0.01% 2816
2022
Q4 		$1.85M Buy
875,191
+193,394
+28% +$587K ﹤0.01% 3082
2022
Q3 		$2.22M Sell
681,797
-96,200
-12% -$369K ﹤0.01% 3049
2022
Q2 		$2.5M Buy
777,997
+178,208
+30% +$991K ﹤0.01% 3036
2022
Q1 		$4.23M Sell
599,789
-4,523
-0.7% -$26.3K ﹤0.01% 2894
2021
Q4 		$4.38M Buy
604,312
+573,380
+1,854% +$5.67M ﹤0.01% 2967
2021
Q3 		$359K Buy
+30,932
New +$354K ﹤0.01% 4180

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management's HUMA Position: Q2 2026 in Review

Geode Capital Management reduced its Humacyte (HUMA) stake by 40% in Q2 2026, selling an estimated $1.36M and leaving 2,185,225 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3229.

Geode Capital Management first reported a position in HUMA in Q3 2021 and has held it in 20 quarters since. The position peaked at $11.1M in Q3 2024. 162 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Geode Capital Management held 2,185,225 shares of Humacyte worth $1.71M as of Q2 2026.
  • Geode Capital Management sold 1,472,883 Humacyte shares in Q2 2026, an estimated $1.36M.
  • Humacyte made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3229 holding.
  • Geode Capital Management first reported a position in Humacyte in Q3 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Humacyte position peaked at $11.1M in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.